Bone mineral density measurements, bone markers and serum vitamin D concentrations in men with chronic non-cirrhotic untreated hepatitis C

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Orsini, Luciana G S ^a   Pinheiro, Marcelo M ^a   Castro, Charlles H M ^a   Silva, Antônio E B ^a   Szejnfeld, Vera L ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; PARATHYROID HORMONE; PHOSPHATE; VITAMIN D; BIOLOGICAL MARKER;

ADULT; AGE; ARTICLE; BODY WEIGHT; BONE DENSITY; BONE FRAGILITY; CONTROLLED STUDY; FEMUR; GENDER; HEPATITIS C; HUMAN; HUMAN CELL; IMMOBILIZATION; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PHYSICAL ACTIVITY; PREVALENCE; SMOKING; SPINE FRACTURE; TROCHANTER; VIRUS LOAD; VITAMIN BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; COMPLICATION; FRAGILITY FRACTURE; LUMBAR VERTEBRA; METABOLISM; PATHOPHYSIOLOGY;

ADULT; BIOLOGICAL MARKERS; BONE DENSITY; CASE-CONTROL STUDIES; FEMUR; HEPATITIS C, CHRONIC; HUMANS; LUMBAR VERTEBRAE; MALE; OSTEOPOROTIC FRACTURES; VITAMIN D;

EID: 84896716650     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081652     Document Type: Article

References (34)

1. World Health Organization website. Available: 〈http://www.who.int/ csr/disease/hepatitis/Hepc.pdf.〉 Acessed 2013 Oct 28.
2. Schwartz KM, Skinner JA (2008) Hepatitis C-associated osteosclerosis: a case report. Skeletal Radiol 37: 679-681.
3. Manganelli P, Giuliani N, Fietta P, Mancini C, Lazzaretti M, et al. (2005) OPG/RANKL system imbalance in a case of hepatitis C-associated osteosclerosis: the pathogenetic key? Clin Rheumatol 24: 296-300. (Pubitemid 40867955)
4. Khosla S, Hassoun AA, Baker BK, Liu F, Zein NN, et al. (1998) Insulin-like growth factor system abnormalities in hepatitis C-associated osteosclerosis. Potential insights into increasing bone mass in adults. J Clin Invest 101: 2165-2173. (Pubitemid 28244100)
5. Corazza GR, Trevisani F, Di Stefano M, De Notariis S, Veneto G, et al. (2000) Early increase of bone resorption in patients with liver cirrhosis secondary to viral hepatitis. Dig Dis Sci 45: 1392-1399. (Pubitemid 30636516)
6. Collier JD, Ninkovic M, Compston JE (2002) Guidelines on the management of osteoporosis associated with chronic liver disease. Gut 50 Suppl 1: i1-9. (Pubitemid 41185465)
7. Leslie WD, Bernstein CN, Leboff MS (2003) AGA technical review on osteoporosis in hepatic disorders. Gastroenterology 125: 941-966. (Pubitemid 37070710)
8. Gonzalez-Calvin JL, Gallego-Rojo F, Fernandez-Perez R, Casado-Caballero F, Ruiz-Escolano E, et al. (2004) Osteoporosis, mineral metabolism, and serum soluble tumor necrosis factor receptor p55 in viral cirrhosis. J Clin Endocrinol Metab 89: 4325-4330. (Pubitemid 39244433)
9. Tsuneoka K, Tameda Y, Takase K, Nakano T (1996) Osteodystrophy in patients with chronic hepatitis and liver cirrhosis. J Gastroenterol 31: 669-678. (Pubitemid 26345533)
10. Solis-Herruzo JA, Castellano G, Fernandez I, Munoz R, Hawkins F (2000) Decreased bone mineral density after therapy with alpha interferon in combination with ribavirin for chronic hepatitis C. J Hepatol 33: 812-817.
11. Nishida N, Komatsu Y, Komeda T, Fukuda Y (2006) Interferon-alpha improves bone resorption and osteopenia in patients with chronic hepatitis C. Hepatol Res 34: 222-227.
12. Urganci N, Gulec SG, Arapoglu M, Vural S, Nuhog A (2005) The effect of ribavirin on bone density in patients with chronic hepatitis C treated with interferon-ribavirin therapy. J Pediatr Gastroenterol Nutr 41: 650-652. (Pubitemid 41579678)
13. Yenice N, Gumrah M, Mehtap O, Kozan A, Turkmen S (2006) Assessment of bone metabolism and mineral density in chronic viral hepatitis. Turk J Gastroenterol 17: 260-266. (Pubitemid 351676929)
14. Duarte MP, Farias ML, Coelho HS, Mendonca LM, Stabnov LM, et al. (2001) Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease. J Gastroenterol Hepatol 16: 1022-1027. (Pubitemid 32947145)
15. Schiefke I, Fach A, Wiedmann M, Aretin AV, Schenker E, et al. (2005) Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol 11: 1843-1847. (Pubitemid 40520782)
16. Lewiecki EM, Gordon CM, Baim S, Leonard MB, Bishop NJ, et al. (2008) International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions. Bone 43: 1115-1121.
17. Dawson DA, Grant BF, Li TK (2005) Quantifying the risks associated with exceeding recommended drinking limits. Alcohol Clin Exp Res 29: 902-908. (Pubitemid 40686562)
18. O'Neill TW, Cooper C, Cannata JB, Diaz Lopez JB, Hoszowski K, et al. (1994) Reproducibility of a questionnaire on risk factors for osteoporosis in a multicentre prevalence survey: the European Vertebral Osteoporosis Study. Int J Epidemiol 23: 559-565. (Pubitemid 24214862)
19. Cooper C, O'Neill T, Silman A (1993) The epidemiology of vertebral fractures. European Vertebral Osteoporosis Study Group. Bone 14 Suppl 1: S89-97.
20. Pinheiro MM, Castro CH, Frisoli A Jr, Szejnfeld VL (2003) Discriminatory ability of quantitative ultrasound measurements is similar to dual-energy X-ray absorptiometry in a Brazilian women population with osteoporotic fracture. Calcif Tissue Int 73: 555-564. (Pubitemid 37517801)
21. Pinheiro MM, Castro CM, Szejnfeld VL (2006) Low femoral bone mineral density and quantitative ultrasound are risk factors for new osteoporotic fracture and total and cardiovascular mortality: a 5-year population-based study of Brazilian elderly women. J Gerontol A Biol Sci Med Sci 61: 196-203. (Pubitemid 43334618)
22. Pedreira PG, Pinheiro MM, Szejnfeld VL (2011) Bone mineral density and body composition in postmenopausal women with psoriasis and psoriatic arthritis. Arthritis Res Ther 13: R16.
23. Kanis JA, Gluer CC (2000) An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation. Osteoporos Int 11: 192-202. (Pubitemid 30216170)
24. Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8: 1137-1148. (Pubitemid 23261108)
25. Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22: 477-501.
26. Kohrt WM, Bloomfield SA, Little KD, Nelson ME, Yingling VR (2004) American College of Sports Medicine Position Stand: physical activity and bone health. Med Sci Sports Exerc 36: 1985-1996.
27. Tanaka T, Latorre MR, Jaime PC, Florindo AA, Pippa MG, et al. (2001) Risk factors for proximal femur osteoporosis in men aged 50 years or older. Osteoporos Int 12: 942-949. (Pubitemid 34001008)
28. Papaioannou A, Kennedy CC, Cranney A, Hawker G, Brown JP, et al. (2009) Risk factors for low BMD in healthy men age 50 years or older: a systematic review. Osteoporos Int 20: 507-518.
29. Felson DT, Zhang Y, Hannan MT, Anderson JJ (1993) Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J Bone Miner Res 8: 567-573. (Pubitemid 23127916)
30. Hoiberg M, Nielsen TL, Wraae K, Abrahamsen B, Hagen C, et al. (2007) Population-based reference values for bone mineral density in young men. Osteoporos Int 18: 1507-1514. (Pubitemid 47512682)
31. Beaupre GS, Lew HL (2006) Bone-density changes after stroke. Am J Phys Med Rehabil 85: 464-472. (Pubitemid 43739332)
32. Vico L, Collet P, Guignandon A, Lafage-Proust MH, Thomas T, et al. (2000) Effects of long-term microgravity exposure on cancellous and cortical weight-bearing bones of cosmonauts. Lancet 355: 1607-1611. (Pubitemid 30240506)
33. Damrongrungruang T, Kuroda S, Kondo H, Aoki K, Ohya K, et al. (2004) A simple murine model for immobilization osteopenia. Clin Orthop Relat Res: 244-251. (Pubitemid 39062777)
34. Hofmann WP, Kronenberger B, Bojunga J, Stamm B, Herrmann E, et al. (2008) Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon alpha and ribavirin therapy. J Viral Hepat 15: 790-79